ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02036502
Brief Title: A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)

First Submitted : January 13, 2014
First Submitted that Met QC Criteria : January 13, 2014
First Posted : January 15, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 24, 2018
Last Update Posted : April 25, 2018